UBS Maintains Neutral on ArcBest, Raises Price Target to $154

Benzinga Newsdesk www.benzinga.com Neutral 55.1%

Neg 0% Neu 55.1% Pos 0%

UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $145 to $154.